Clinical trials for Chronic lymphocytic leukaemia

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Chronic lymphocytic leukaemia. For all clinical trials, go to clinical trials search

This list shows clinical trials for Chronic lymphocytic leukaemia

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Chronic lymphocytic leukaemia
Title Recruitment status Location
GA101 (obinutuzumab) monocLonal Antibody as Consolidation Therapy In CLL Recruiting United Kingdom
Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers Recruiting United Kingdom
Assessment of venetoclax in combination with Ibrutinib in patients with Chronic Lymphocytic Leukaemia Recruiting United Kingdom
Dose Escalation Study to Evaluate the Safety, Tolerability and Biological Activity of a Single Dose of UCART19 in Patients With Relapsed / Refractory (R/R) B-cell Acute Lymphoblastic Leukaemia (ALL) and Chronic Lymphocytic Leukaemia (CLL) Recruiting United Kingdom
CALiBRe: Assessment of the Mechanism of Action of idelalisib (CAL101) in B-cell Receptor Pathway Inhibition in CLL Recruiting United Kingdom
SPC2996 in Chronic Lymphocytic Leukaemia An open-labelled, international multicenter dose escalating, phase I/II study of SPC2996, an LNA antisense molecule against Bcl-2, in patients with relapsed or refractory Chronic Lymphocytic Leukaemia - SPC2996 in Chronic Lymphocytic Leukaemia Not Recruiting United Kingdom
SPC2996 in Chronic Lymphocytic Leukaemia An open-labelled, international multicenter dose escalating, phase I/II study of SPC2996, an LNA antisense molecule against Bcl-2, in patients with relapsed or refractory Chronic Lymphocytic Leukaemia - SPC2996 in Chronic Lymphocytic Leukaemia Not Recruiting United Kingdom
Efficacy and safety of olaparib in relapsed and refractory chronic lymphocytic leukaemia patients with an 11q deletion or ATM mutation and relapsed/refractory patients with T-prolymphocytic leukaemia and mantle cell lymphoma Not Recruiting United Kingdom
Study of a new drug combination to treat Leukemia Authorised United Kingdom
Study of a new drug combination to treat Leukemia Authorised United Kingdom

Page last reviewed: 22/03/2016

Next review due: 22/11/2018